Get Premium to unlock powerful stock data

Odonate Therapeutics Inc (ODT) CEO Kevin C Tang Bought $2.1 million of Shares

Author's Avatar
insider
Jun 11, 2019
Article's Main Image

CEO of Odonate Therapeutics Inc (

ODT, Financial) Kevin C Tang bought 76,308 shares of ODT on 06/07/2019 at an average price of $27.36 a share. The total cost of this purchase was $2.1 million.

Odonate Therapeutics Inc is a pharmaceutical company which is engaged in the development of therapeutics which improves and extend the lives of patients with cancer. It is developing tesetaxel an chemotherapy agent used in the treatment of cancer. Odonate Therapeutics Inc has a market cap of $665.450 million; its shares were traded at around $24.88 .

CEO Recent Trades:

  • CEO, 10% Owner Kevin C Tang bought 76,308 shares of ODT stock on 06/07/2019 at the average price of $27.36. The price of the stock has decreased by 9.06% since.
  • CEO, 10% Owner Kevin C Tang bought 93,692 shares of ODT stock on 06/05/2019 at the average price of $24.92. The price of the stock has decreased by 0.16% since.

For the complete insider trading history of ODT, click here

.
  • CEO Buys, CFO Buys: Stocks that are bought by their CEO/CFOs.
  • Insider Cluster Buys: Stocks that multiple company officers and directors have bought.
  • Double Buys:: Companies that both Gurus and Insiders are buying
  • Triple Buys: Companies that both Gurus and Insiders are buying, and Company is buying back.

» Take a Free Trial of Premium Membership

Not a Premium Member of GuruFocus? Sign up for a free 7-day trial here.
Rating:
0 / 5 (0 votes)

Please Login to leave a comment

Author's Avatar

insider